Skip to main content

This website contains promotional content and is intended for Healthcare Professionals based in the United States only.

Track Respiratory Pathogen Activity at Your Local Level

Wastewater data help track the activity of respiratory pathogens. These data help detect the presence and quantities of pathogens within the larger community.1,2

  
On this page:

Up-to-date pathogen activity

Click on a disease state tab and then on state or county to see your regional or local circulation of that pathogen.

Map shows interpolated wastewater concentrations for all US counties. Direct wastewater data are not available for every county. Values are based on actual samples from a subset of wastewater treatment facilities and modeled estimates for counties without direct measurements. For SARS-CoV-2, the color scale on the map is designed to use data exclusively from 2022 and later, with the highest activity levels being correlated with peak activity during these years. Wastewater samples contain a mix of DNA and RNA from bacteria, viruses, animals, humans, and other living things.2
  
All wastewater data are presented as is and have not been verified by Sanofi. Wastewater activity should not be interpreted in isolation as the absence or presence of disease risk or to assess individual patient risk.

Tracking pathogen circulation can alert you to when patients may be at elevated risk of exposure2

Wastewater samples collected weekly are analyzed for the presence of biomarkers of infection, most commonly pathogen DNA or RNA. The genetic material can be shed when infected persons wash their hands, brush their teeth, take a shower, or use the bathroom.  
    
As Biobot Analytics samples are processed, data and models are updated on a rolling basis multiple times per week.
    
Biobot collects wastewater samples from communities across the US, representing ~23% of the US population. Interpolation-generated, county-level enhanced datasets are updated weekly, representing 100% of US counties.  
    
Biobot's model estimates the concentration of pathogens in wastewater across the US through an interpolation approach that makes use of population density and sampling location data, among other information. The model uses a statistical machine learning model and does not use generative AI. 

What the data can tell us1

  • Estimated circulation of these respiratory pathogens in your local environment
  • An early warning that infectious diseases may be spreading in a community
  • An efficient approach that can detect infection in a community, regardless of whether people have symptoms or seek medical care
  • Data for communities where patients aren't always able to get tested for infectious diseases

These activity levels may correlate with clinical burden and may provide a visual aid to guide prevention steps.2

Wastewater detection levels may remain elevated even as community circulation wanes2

At times, the map may report elevated levels of circulating pathogens even as community circulation wanes. Two potential reasons for this are (in an example for RSV):

  1. Prolonged shedding: Infected people may continue to shed the virus for days after symptoms resolve 
  2. Subclinical or mild infections: Some individuals, especially older children and adults, may have mild or asymptomatic infections that don’t require hospitalization or testing

    
Frequently consulting the wastewater map can keep you informed of circulating viral activity trends, even at times believed to have reduced circulation.

Additional details about the data

What can I do as a clinician?

You can use this tool with other data sources to stay informed about respiratory pathogen activity

Checking wastewater maps can help ensure that patients are getting immunized at recommended times, before respiratory pathogen signals become high.

During periods of high circulation, it can also help ensure early identification of signs and symptoms of respiratory disease.

To order immunizations or visit disease-state websites, go to:

Which pathogens are captured in these wastewater data?2,3

Two respiratory pathogens that circulate in wastewater and are monitored with Biobot data are:

  • RSV
  • SARS-CoV-2, the causative agent of COVID-19

RSV

RSV is seasonal, with infections peaking at certain times of the year. A typical RSV season runs roughly from fall through spring in most of the continental US.4,5
   
During the COVID-19 pandemic, RSV detection became more unpredictable, with off-season resurgences in some regions. Wastewater surveillance can help identify when local RSV seasons begin and end.5,6

Signs and symptoms7-9

RSV shares similar characteristics to those of other respiratory viruses, including:

  • Runny nose
  • Congestion
  • Decreased appetite
  • Coughing
  • Sneezing
  • Fever (many young infants will not present with fever)
  • Wheezing 

In very young infants, symptoms may only include irritability, decreased activity, and breathing difficulties.

Immunization is an important step in keeping infants safe from serious RSV lung infection10

The AAP recommends that all infants younger than 8 months of age who do not have documented maternal vaccination during pregnancy get immunized with a monoclonal antibody. This is applicable whether they are born during or are entering their first RSV season.
  
The AAP recommendation also includes infants and children between 8 months and 19 months of age who are at high risk of severe RSV disease and are entering their second RSV season.

About Biobot data and RSV2

Biobot internal analyses show that RSV levels in wastewater rise prior to hospitalizations. Wastewater can also detect clusters of RSV. Wastewater data do not distinguish between RSV A and RSV B.
   
The above information was provided by Biobot and has not been verified by Sanofi.

COVID-193,9

COVID-19 is a widely recognized respiratory disease that can present much like other respiratory illnesses, such as the common cold, the flu, or pneumonia. COVID-19 may affect other systems beyond the respiratory system. Variants of SARS-CoV-2, the virus that causes COVID-19, have developed, as is common with viruses.
   
Most patients with COVID-19 have mild symptoms, but some can progress to severe illness.

Signs and symptoms8

COVID-19 patients can have wide-ranging symptoms, from mild to severe (some may start as mild but progress to become severe). Symptoms may appear 2 days to 2 weeks following exposure. Also, symptoms may change as new variants emerge and can vary with vaccination status. Possible symptoms include, but are not limited to:

  • Fever or chills
  • Cough
  • Dyspnea
  • Sore throat
  • Congestion or runny nose
  • Anosmia
  • Fatigue
  • Myalgia
  • Headache
  • Nausea or vomiting
  • Diarrhea

For more information about Biobot data regarding SARS-CoV-2 and COVID-19, please visit the Biobot website.
  
Biobot is a third-party company and not controlled by Sanofi.

Sanofi & Biobot Analytics partnership

Our commitment to protecting health

At Sanofi, we’re dedicated to helping protect people of all ages from respiratory illnesses, including RSV and COVID-19. Through our partnership with Biobot Analytics, we regularly provide healthcare providers with timely, updated respiratory pathogen activity data to support informed decisions and help protect communities.

AAP, American Academy of Pediatrics; AI, artificial intelligence; CDC, Centers for Disease Control and Prevention; PCR, polymerase chain reaction; PMMoV, pepper mild mottle virus; RSV, respiratory syncytial virus; RSV-NET, Respiratory Syncytial Virus Hospitalization Surveillance Network; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

References: 1. About wastewater data. Centers for Disease Control and Prevention. Updated August 14, 2026. Accessed September 17, 2026. https://www.cdc.gov/nwss/about-data.html 2. Data on File. Sanofi. 3. About COVID-19. Centers for Disease Control and Prevention. Updated June 13, 2024. Accessed September 17, 2026. https://www.cdc.gov/COVID/about/index.html 4. About RSV. Centers for Disease Control and Prevention. Updated December 30, 2025. Accessed September 17, 2026. https://www.cdc.gov/rsv/about/index.html 5. Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217(9):1356-1364. 6. Abu-Raya B, Viñeta Paramo M, Reicherz F, et al. Why has the epidemiology of RSV changed during the COVID-19 pandemic? EClinicalMedicine. 2023;61:102089. 7. Symptoms and care of RSV. Centers for Disease Control and Prevention. Updated February 20, 2026. Accessed September 17, 2026. https://www.cdc.gov/rsv/symptoms/index.html 8. Symptoms of COVID-19. Centers for Disease Control and Prevention. Updated March 10, 2025. Accessed September 17, 2026. https://www.cdc.gov/covid/signs-symptoms/index.html 9. How to tell the difference between flu, RSV, COVID-19, and the common cold. National Foundation for Infectious Diseases. Accessed October 28, 2026. https://www.nfid.org/resource/how-to-tell-the-difference-between-flu-rsv-covid-19-and-the-common-cold/ 10. Recommended child and adolescent immunization schedule for ages 18 years or younger. American Academy of Pediatrics. Updated September 2, 2026. Accessed September 17, 2026. https://downloads.aap.org/AAP/PDF/AAP-Immunization-Schedule.pdf

MAT-US-2610117-v1.0-10/2026